The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study

Author:

Schofield Deborah1,Kraindler Joshua1ORCID,Tan Owen1,Shrestha Rupendra N1ORCID,West Sarah1,Hart Natalie1,Tan Liny23,Ma Alan234ORCID,Grigg John R234,Jamieson Robyn V234

Affiliation:

1. GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie Business School Macquarie University Sydney NSW

2. Children's Medical Research Institute, Sydney Children's Hospitals Network University of Sydney Sydney NSW

3. Save Sight Institute University of Sydney Sydney NSW

4. The University of Sydney Sydney NSW

Abstract

AbstractObjectivesTo estimate the health care and societal costs of inherited retinal diseases (IRDs) in Australia.Design, setting, participantsMicrosimulation modelling study based on primary data — collected in interviews of people with IRDs who had ophthalmic or genetic consultations at the Children's Hospital at Westmead or the Save Sight Institute (both Sydney) during 1 January 2019 – 31 December 2020, and of their carers and spouses — and linked Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Schedule (PBS) data.Main outcome measuresAnnual and lifetime costs for people with IRDs and for their carers and spouses, grouped by payer (Australian government, state governments, individuals, private health insurance) and type (health care costs; societal costs: social support, National Disability Insurance Scheme (NDIS), income and taxation, costs associated with caring for family members with IRDs); estimated annual national cost of IRDs.ResultsNinety‐four people (74 adults, 20 people under 18 years; 55 girls and women [59%]) and 30 carers completed study surveys (participation rate: adults, 66%; children, 66%; carers, 63%). Total estimated lifetime cost was $5.2 million per person with an IRD, of which 87% were societal and 13% health care costs. The three highest cost items were lost income for people with IRDs ($1.4 million), lost income for their carers and spouses ($1.1 million), and social spending by the Australian government (excluding NDIS expenses: $1.0 million). Annual costs were twice as high for people who were legally blind as for those with less impaired vision ($83 910 v $41 357 per person). The estimated total annual cost of IRDs in Australia was $781 million to $1.56 billion.ConclusionAs the societal costs associated with IRDs are much larger than the health care costs, both contributors should be considered when assessing the cost‐effectiveness of interventions for people with IRDs. The increasing loss of income across life reflects the impact of IRDs on employment and career opportunities.

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

General Medicine

Reference24 articles.

1. Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps

2. A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010

3. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases

4. An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK

5. GriggJ JamiesonR ChenF et al.Guidelines for the assessment and management of patients with inherited retinal diseases (IRD). Royal Australia and New Zealand College of Ophthalmologists; 1 Feb2020.https://ranzco.edu/policies_and_guideli/guidelines‐for‐the‐assessment‐and‐management‐of‐patients‐with‐inherited‐retinal‐degenerations‐ird(viewed Mar 2022).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3